Your browser doesn't support javascript.
Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19.
Futatsugi, Hiroyuki; Iwabu, Masato; Okada-Iwabu, Miki; Okamoto, Koh; Amano, Yosuke; Morizaki, Yutaka; Kadowaki, Takashi; Yamauchi, Toshimasa.
  • Futatsugi H; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Iwabu M; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okada-Iwabu M; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okamoto K; Laboratory for Advanced Research on Pathophysiology of Metabolic Diseases, The University of Tokyo, Tokyo, Japan.
  • Amano Y; Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan.
  • Morizaki Y; Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan.
  • Kadowaki T; Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan.
  • Yamauchi T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Front Cardiovasc Med ; 7: 593061, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-1485041
ABSTRACT
Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio pronóstico Idioma: Inglés Revista: Front Cardiovasc Med Año: 2020 Tipo del documento: Artículo País de afiliación: Fcvm.2020.593061

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio pronóstico Idioma: Inglés Revista: Front Cardiovasc Med Año: 2020 Tipo del documento: Artículo País de afiliación: Fcvm.2020.593061